Development of Targeted New Agents for Children with Cancer

NCI ’ s Center for Cancer Research (CCR) Grand Rounds Dr. Peter Adamson is Chair of the Children ’ s Oncology Group (COG), a National Cancer Institute (NCI) supported international consortium of more than 220 childhood centers that conducts clinical-translational research, including large-scale clinical trials, in children with cancer. Dr. Adamson is Board Certified in Pediatric Hematology/Oncology and in Clinical Pharmacology. He currently serves on the National Cancer Advisory Board (NCAB) and is an internationally recognized leader in pediatric cancer drug development. Prior to becoming Chair of the COG in 2011, Dr. Adamson served as Director for Clinical and Translational Research at The Children ’ s Hospital of Philadelphia, as well as Chief of the Division of Clinical Pharmacology and Therapeutics. Other key roles that he has held include co-Director of the University of Pennsylvania ’ s - CHOP Clinical Translational Science Award (CTSA), Program Director of the General Clinical Research Center (GCRC) and Principal Investigator of CHOP ’ s Pediatric Pharmacology Research Unit (PPRU). His laboratory research focuses on the clinical pharmacology of new drugs for childhood cancer.Air date: 11/18/2016 12:00:00 PM
Source: Videocast - All Events - Category: Journals (General) Tags: Upcoming Events Source Type: video